MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-05-2023
Heska Corporation ROE Ratio 2011-2026 | HSKA
Annual ROE Ratio Heska Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.71 | -0.26 | -5.02 | -0.95 | 4.78 | 9.91 | 12.08 | 8.25 | 4.9 | -2.37 | 2.46 | 4.43 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 12.08 | -5.02 | 2.79 |
Quarterly ROE Ratio Heska Corporation
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.9 | -3.69 | -5.99 | -6.31 | -5.5 | -2.73 | -2.25 | -3.63 | -5.41 | -5.87 | -6.99 | -5.38 | -3.32 | -0.95 | 3.0 | 1.84 | 3.55 | 4.78 | 0.88 | 5.32 | 7.08 | 9.91 | 14.94 | 15.72 | 15.3 | 12.08 | 11.31 | 9.68 | 8.67 | 8.25 | 6.61 | 5.35 | 5.48 | 4.9 | 5.84 | 5.38 | -1.36 | -2.54 | -4.24 | -4.82 | 0.45 | 2.46 | 2.67 | 3.33 | 3.73 | 4.43 | 0.59 | 0.94 | 1.89 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 15.72 | -6.99 | 2.28 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Biomerica
BMRA
|
-121.14 | $ 2.13 | -2.74 % | $ 4.89 M |  USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M |  Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
4.0 | $ 25.75 | 3.0 % | $ 715 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 195.6 | 0.17 % | $ 21.7 B | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | USA |
 |
DexCom
DXCM
|
30.46 | $ 65.94 | -1.51 % | $ 25.7 B | USA |
 |
Co-Diagnostics
CODX
|
-41.08 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | $ 104.91 | - | $ 19.8 B | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 16.33 | 5.29 % | $ 494 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 158.0 | 2.86 % | $ 7.83 B | USA |
 |
IQVIA Holdings
IQV
|
20.91 | $ 166.96 | 0.54 % | $ 28.7 B | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
-59.42 | $ 1.46 | 26.96 % | $ 1.86 M | USA |
 |
Interpace Biosciences
IDXG
|
-302.3 | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
IDEXX Laboratories
IDXX
|
65.99 | $ 578.51 | 0.22 % | $ 46.5 B | USA |
 |
Agilent Technologies
A
|
22.45 | $ 112.02 | 0.65 % | $ 34.1 B | USA |
 |
Illumina
ILMN
|
-51.54 | $ 123.79 | -0.43 % | $ 19.7 B | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 100.35 | 0.65 % | $ 8.28 B |  Irlanda |
 |
DarioHealth Corp.
DRIO
|
-61.41 | $ 7.5 | -6.13 % | $ 29.9 M | Israel |
 |
Guardant Health
GH
|
419.18 | $ 84.9 | -0.33 % | $ 10.6 B | USA |
 |
QIAGEN N.V.
QGEN
|
2.34 | - | - | $ 10.6 B |  Niderland |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 17.56 | 2.39 % | $ 936 M | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 75.73 | -0.92 % | $ 5.11 B | USA |
 |
Celcuity
CELC
|
-96.68 | $ 106.75 | 0.67 % | $ 4.21 B | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 456.93 | 0.98 % | $ 13.2 B | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 264.42 | 0.54 % | $ 22 B | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 239.07 | 2.87 % | $ 25.5 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-99.43 | $ 4.66 | 1.75 % | $ 432 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-449.46 | $ 3.48 | 0.87 % | $ 1.87 M | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 8.1 | 1.76 % | $ 1.04 B | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 17.51 | 1.1 % | $ 392 M | USA |
 |
Natera
NTRA
|
-77.62 | $ 200.09 | 2.46 % | $ 19.7 B | USA |
 |
OPKO Health
OPK
|
1.03 | $ 1.15 | 2.68 % | $ 798 M | USA |
 |
Pacific Biosciences of California
PACB
|
-10214.54 | $ 1.39 | 4.51 % | $ 417 M | USA |
 |
RadNet
RDNT
|
-1.71 | $ 61.74 | 0.41 % | $ 4.64 B | USA |